|
Pharmanex Clinical Study Report
Appel LJ, Miller ER3rd, Seidler AJ, et al. Does supplementation of diet with ‘fish
oil’ reduce blood pressure? A meta-analysis of controlled clinical trials.
Arch Intern Med. 1993; 153: 1429–1438.
Amaducci, L, Crook, TH, Lippi, A, et al. Use of phosphatidylserine in Alzheimer’s
Disease. Ann NY Acad Sci 1991;640:245-49.
Belluzzi A, Brignola C, Campieri M, et al. Effect of an enteric-coated fish
oil preparation on relapses in Crohn’s disease. N Engl J Med 1996;334:1557-1560.
Boelsma E, Hendriks HF, Roza L. Nutritional skin care: health effects of micronutrients
and fatty acids. Am J Clin Nutr 2001;73:853-864.
Brenna JT. Efficiency of conversion of alpha linolenic acid to long chain n-3
fatty acids in man. Curr Opin Clin Nutr Metab Care 2002;5:127-132.
Burdge GC, Wooten SA. Conversion of alpha linolenic acid to eicosapentaenoic,
docosapentaenoic and docosahexaenoic acid in young women. Br J Nutr 2002;88:411-420.
Burdge GC, Jones AC, Wooton SA. Eicosapentaenoic and docosapentaenoic acids
are the principle products of alpha-linolenic acid metabolism in young men.
Br J Nutr 2002;88:355-363.
Burr ML, Fehily AM. Fatty fish and heart disease: A randomized controlled trial.
World Rev Nutr Diet 1991;66:306-312.
Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and
fibre intakes on death and myocardial reinfarction: diet and reinfarction trial
(DART). Lancet. 1989; 2: 757–761.
Calder PC, Yaqoob P, Thies F, et al. Fatty acids and lymphocyte functions.
Br J Nutr 2002;87(Suppl):S31-S48.
Chapman and Hall. Unsaturated fatty acids: nutritional and physiological significance.
British Nutrition Foundation. 1992. London
Colin A, Reggers J, Castronovo V, Ansseau M. Lipids, depression and suicide.
Encephale 2003;29:49-58.
Connor SJ, Conner WE. Are fish oils beneficial in the prevention and treatment
of coronary artery disease? Am J Clin Nutr 66(suppl):1020S-1031S, 1997.
Conquer JA, Tierney MC, Zecevic J, et al. Fatty acid analysis of blood plasma
of patients with Alzheimer’s disease, other types of dementia, and cognitive
impairment. Lipids 2000;35:1305-1312.
Davidson MR, Maki KC, Kalkowski J, et al. Effects of docosahexaenoic acid on
serum lipoproteins in patients with combined hyperlipidemia: A randomized, double-blind,
placebo-controlled trial. J Am Coll Nutr 1997;16:236-243.
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E
after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo
Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet.
1999; 354: 447–455.
Emken EA, Adlof RO, Gulley RM. Dietary linoleic acid influences desaturation
and acylation of deuterium-labeled linoleic and linolenic acids in young adult
males. Biochem Biophys Acta. 1994;1213:277-288.
Emsley R, Myburgh C, Oosthuizen P, van Rensburg SJ. Randomized, placebo-controlled
study of ethy-eicosapentaenoic acid as supplemental treatment in schizophrenia.
Am J Psychiatry 2002;159:1596-1598.
Endres S, Meydani SN, Dinarello CA. Effects of omega-3 fatty acid supplements
on ex vivo synthesis of cytokines in human volunteers. World Rev Nutr Diet 1991;66:401-406.
Eritsland J, Arnesen H, Gronseth K, et al. Effect of dietary supplementation
with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol.
1996; 77: 31–36.
Fenton WS, Dickerson F, Boronow J, et al. A placebo-controlled trial of omega-3
fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms
and cognitive impairment in schizophrenia. Am J Psychiatry 2001:158:2071-2074.
Freeman MP. Omega-3 fatty acids in psychiatry: a review. Ann Clin Psychiatry
2000;12:159-165.
Friedburg CE, Janssen MJ, Heine RJ, Grobbee DE. Fish oil and glycemic control
in diabetes. A meta-analysis. Diabetes Care 1998;21:494-500.
Gerster H. Can adults adequately convert alpha-linolenic acid (18:3n-3) to
eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3)
Haag M. Essential fatty acids and the brain. Can J Psychiatry 2003;48:195-203.
Haglund O, et al. The effect of fish oil on triglycerides, cholesterol, fibrinogen
and malondialdehyde in humans supplemented with vitamin E. J Nutr 1991;121:165-169.
Hamazaki T, Sawazaki S, Itomura M, et al. The effect of docosahexaenoic acid
on aggression in young adults. A placebo-controlled double-blind study. J Clin
Invest 1996;1129-1133.
Harris WS. n-3 Fatty acids and serum lipoproteins: human studies. Am J Clin
Nutr. 1997; 65 (5 Suppl): 1645S–1654S.
Harris WS, Rambjor GS, Windsor SL, Diederich D. N-3 fatty acids and urinary
excretion of nitric oxide metabolites in humans. Am J Clin Nutr 1997;65:459-464.
Harris WS. Fish oils and plasma lipid and lipoprotein metabolism in humans:
a critical review. J Lipid Res 30:785-805, 1989.
He K, Rimm EB, Merchant A, et al. Fish consumption and risk of stroke in men.
JAMA 2002;288:3130-3136.
Hirata, F, Axelrod, J. Phospholipid methylation and biological signal transmission.
Science 1980;209:1082-90.
Horrobin DF, Jenkins K, Bennett CN, Christie WW. Eicosapentaenoic acid and
arachidonic acid: collaboration and not antagonism is the key to biological
understanding. Prostaglandins Leukot Essent Fatty Acids 2002;66:83-90.
Iso H, Rexrode HM, Stampfer MJ, et al. Intake of fish and omega-3 fatty acids
and risk of stroke in women. JAMA 2001:304-312.
Jackson MJ, Jackson MJ, McArdle F et al. Effects of micronutrient supplements
on u.v.-induced skin damage. Proc.Nutr.Soc 2002;61:187-9.
Jain S, Gaiha M, Bhattacharjee J, Anuradha S. Effects of low-dose omega-3 fatty
acid substitution in type 2 diabetes mellitus with special reference to oxidative
stress—a prospective preliminary study. J Assoc Physicians India 2002;50:1028-1033.
James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory
mediator production. Am J Clin Nutr 2000;71:343S-348S.
Joy CB, Mumby-Croft R, Joy LA. Polyunsaturated fatty acid (fish or evening
primrose oil) for schizophrenia. Cochrane Databse Syst Rev 2000;CD001257.
JSS Medical Research, Inc. Evaluation of the effects of Neptune Krill OilTM
on the management of hyperlipidemia. June 7, 2003.
JSS Medical Research, Inc. Evaluation of the effects of Neptune Krill OilTM
on UV Induced Skin Cancer. 2003.
Julius U. Fat modification in the diabetes diet. Exp Clin Endocrinol Diabetes
2003;111:60-65.
Kinsella J, Lokesh B, Stone R. Dietary n-3 polyunsaturated fatty acids and
amelioration of cardiovascular disease: possible mechansims. Am J Clin Nutr
1990;52:1-28.
Krauss RM et a l. AHA Dietary Guidelines. Revision 2000: A statement for healthcare
professionals from the nutrition committee of the American Heart Association.
Circ. 2000;102:2296-2311.
Kremer JM. Effects of modulation of inflammatory and immune parameters in patients
with rheumatic and inflammatory disease receiving dietary supplementation of
n-3 and n-6 fatty acids. Lipids 1996;31:S243-S247.
Kremer JM, Robinson DR. Studies of dietary supplementation with omega-3 fatty
acids in patients with rheumatoid arthritis. World Rev Nutr Diet 1991;66:367-382.
Kremer JM, Jubiz W, Michalek A, et al. Fish-oil fatty acid supplementation
in active rheumatoid arthritis. Ann Int Med 1987;106:497-503.
Kris-Etherton PM, Taylor DS, Yu-Poth S, et al. Polyunsaturated fatty acids
in the food chain the United States. Am J Clin Nutr. 2000;71(1 Suppl):179S-188S.
Laugharne JD, Mellor JE, Peet M. Fatty acids and schizophrenia. Lipids 1996;31
Suppl:S163-S165.
Mensink R, Zock P, Katan M, Hornstra G. Effect of dietary cis and trans fatty
acids on serum lipoprotein[a] levels in humans. J Lipid Res 1992;33:1493-1501.
Michael A. Schimidt, Brain Builing Nutrition chapter 15, Frog Ltd, Berkely,
California, pg 208-212Put, A, eta al. Clinical efficacy of essential phospholipids
in patients chronically exposed to organic solvents. J Intl Med Res 1993;21:185-91.
Morris MC, Evans DA, Bienias JL, et al. Consumption of fish and n-3 fatty acids
and risk of incident Alzheimer disease. Arch Neurol 2003;60:923-924.
Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis
of controlled trials. Circulation. 1993; 88: 523–533.
Murray, M. Encyclopedia of Nutritional Supplements, Rocklin, CA: Prima Publishing,
1996, pp. 239-278.
Nakamura N, Hamazaki T, Kobayashi M, et al. Effect of eicosapentaenoic acids
on remnant-like particles, cholesterol concentrations and plasma fatty acid
composition in patients with diabetes mellitus. In Vivo 1998; 12:311-314.
Nair SSD, Leitch JW, Falconer JW, et al. Prevention of cardiac arrhythmia by
dietary (n-3) polyunsaturated fatty acids and their mechanism of action. J Nutr
1997;127:383-393.
Nkondjock A, Shatenstein B, Maisonneuve P, Ghadirian P. Specific fatty acids
and human colorectal cancer: an overview. Cancer Detect Prev 2003;27(1):55-66.
Nomura S, Kanazawa S, Fukuhara S. Effects of eicosapentaenoic acid on platelet
activation markers and cell adhesion molecules in hyperlipidemic patients with
type 2 diabetes mellitus. J Diabetes Complications 2003;17:153-159.
Otsuka M. Analysis of dietary factors in Alzheimer’s disease: clinical
use of nutritional intervention for prevention and treatment of dementia. Nippon
Ronen Igakkai Zasshi 2000;37:970-973.
Peet M, Horrobin DF, E-E Multicentre Study Group. A dose-ranging exploratory
study of the effects of ethyl-eicosapentenoate in patients with persistent schizophrenic
symptoms. J Psychiatr Res 2002;36:7-18.
Peet M, Brind J, Ramchand CN, et al. Two double-blind placebo-controlled pilot
studies of eicosapentaenoic acid in the treatment of schizophrenia. Schizophr
Res 2001;49:243-251.
Peet M, Laugharne JD, Mellor J, Ramchand CN. Essential fatty acid deficiency
in erythrocyte membranes from chronic schizophrenic patients, and the clinical
effects of dietary supplementation. Prostaglandins Leukotrienes and Essential
Fatty Acids 1996;55:71-75.
Radack K, Deck C, Huster G. Dietary supplementation with low-dose fish oils
lowers fibrinogen levels: A randomized, double-blind controlled study. Ann Intern
Med 1989;111:757-758.
Rhodes LE, Shahbakhti H, Azurdia RM, et al. Effect of eicosapentaenoic acid,
an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans.
An assessment of early genotoxic markers. Carcinogenesiss 2003;24:919-925.
Rhodes LE, Durham BH, Fraser WD, Friedmann PS. Dietary fish oil reduces basal
and ultraviolet B-generated PGE2 levels in skin and increases the threshold
to provocation of polymorphic light eruption. J Invest Dermatol 1995;105:532-535.
Rhodes LE, O’Farrell S, Jackson MJ, Friedmann PS. Dietary fish-oil supplementation
in humans reduces UVB-erythemal sensitivity but increases epidermal lipid peroxidation.
J Invest Dermatol 1994;103(2):151-154.
Ristic V, Ristic G. Role and importance of dietary polyunsaturated fatty acids
in the prevention and therapy of atherosclerosis. Med Pregl 2003;56:50-53.
Salem N, Jr., Pawlosky R, Wegher B, Hibbeln J. In vivo conversion of linoleic
acid to arachidonic acid in human adults. Prostaglandins Leukot Essent Fatty
Acids 1999;60:407-410.
Shapiro, J.A., et al. Diet and rheumatoid arthritis in women: a possible protective
effect of fish consumption. Epidemiology, 1996 May, 7(3)256-63.
Skerrett PJ, Henneckens CH. Consumption of fish and fish oils and decreased
risk of stroke. Prev Cardiol 2003;6:38-41.
Simpoulos AP, Leaf A, Salen N.,Jr. Conference Report: Workshop on the essentiality
of and recommended dietary intakes for omega-6 and omega-3 fatty acids. J Am
Coll Nutr 1999;18:487-489, 1999.
Simpoulos AP, Leaf A, Salmen N Jr. Essentiality of and recommended dietary
intakes for omega 6 and omega 3 fatty acids. Ann Nutr Metab. 1999;43:127-130.
Simopoulos, AT. Omega-3 fatty acids. In Spiller, GE, ed. Handbook of Lipids
in Human Nutrition. Boca Raton, Florida: CRC Press, 1996:68.
Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and
development. Am J Clin Nutr 1991;54:438-463.
Singh RB, Niaz MA, Sharma JP, et al. Randomized, double-blind, placebo-controlled
trial of fish oil and mustard oil in patients with suspected acute myocardial
infarction: the Indian experiment of infarct survival-4. Cardiovasc Drugs Ther.
1997; 11: 485–491.
Sirtori CR, Galli C. N-3 fatty acids and diabetes. Biomed Pharmacother 2002;56:397-406.
Sperling RI. Effects of dietary fish oils on leukocyte leukotriene and PAF
generation and on neutrophil chemotaxis. World Rev Nutr Diet 1991;66:391-400.
Tapiero H, ba GN, Couvreur P, Tew KD. Polyunsaturated fatty acids (PUFA) and
eicosanoids in human health and pathologies. Biomed Pharmacother 2002;56:215-222.
Thies F, Garry JM, et al. Association of n-3 polyunsaturated fatty acids with
stability of atherosclerotic plaques: a randomised controlled trial. Lancet.
2003 Feb 8:361(9356):477-85.
Tully AM, Roche HM, Doyle R, et al. Low serum choelsteryl ester-docosahexaenoic
acid levels in Alzheimer’s disease: a case-control study. Br J Nutr 2003;89(4):483-489.
Veierod MB, Thelle DS, Laake P. Diet and risk of cutaneous malignant melanoma:
a prospective study of 50,757 Norwegian men and women. Int J Cancer 1997;71(4):600-604.
Volker D, Fitzgerald P, Major G, Garg M. Efficacy of fish oil concentrate in
the treatment of rheumatoid arthritis. J Rheumatol. 2000 Oct;27(10):2343-6.
Von Schacky C, Angerer P, Kothny W, et al. The effect of dietary omega-3 fatty
acids on coronary atherosclerosis: a randomized, double-blind, placebo-controlled
trial. Ann Intern Med. 1999; 130: 554–562.
Willatts P. Long chain polyunsaturated fatty acids improve cognitive development.
J Fam Health Care. 2002;12(6 Suppl):5.
Yosefy C, Viskoper JR, Laszt A, et al. The effect of fish oil on hypertension,
plasma lipids and hemostasis in hypertensive, obese, dyslipidemic patients with
and without diabetes mellitus. Prostaglandins Leukotrienes & Essential Fatty
Acids 1999;61:83-87.
Zak A, Zeman M, Tvrzicka E, Stolba P. The effect of fish oil on metabolic parameters
in patients with type 2 diabetes mellitus associated with dyslipidemia. Cas
Lek Cesk 1996;135:354-359.
Ziboh VA. The significance of polyunsaturated fatty acids in cutaneous biology.
Lipids 1996;31(Suppl):S249-S253.
|